Clinical Trials Directory

Trials / Completed

CompletedNCT07513597

Assessment of the Effects of a Daily Supplement 4Life Transfer Factor Vista Containing AREDS2 Formula on Skin Carotenoid Levels Using a Non-invasive Detection

Assessment of the Effects of a Daily Supplement 4Life Transfer Factor Vista Containing the AREDS2 Formula on Skin Carotenoid Levels Using a Non-Invasive Method

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
4Life Research, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of the clinical study is to evaluate the impact of daily use of a dietary supplement TF Vista containing AREDS2 formula ingredients, astaxanthin (Haematococcus pluvialis) microalgae, bilberry (Vaccinium myrtillus) fruit powder and black currant (Ribes nigrum) fruit powder organic on skin carotenoid levels over an 8-week period for a Cohort 1(n= 20 participants) and 12 weeks for a Cohort 2 (n= 4 participants). Results will be compared using two devices - the Veggie Meter and the Samsung Watch - both of which utilize reflection spectroscopy technology. For Cohort 2 (n = 4 participants), in addition to assessing skin carotenoid levels, the study will also evaluate changes in macular pigment optical density (MPOD) before and after supplementation.

Conditions

Interventions

TypeNameDescription
OTHERDietary SupplementStudy product 4Life TF Vista contains Tri Factor (bovine colostrum and egg yolk), bilberry (Vaccinium myrtillus) fruit powder, black currant (Ribes Nigrum) powder, lutein, zeaxanthin (Tagetes erecta), vitamin C, vitamin A, vitamin E, zinc, and copper.

Timeline

Start date
2025-10-16
Primary completion
2025-12-17
Completion
2026-02-14
First posted
2026-04-07
Last updated
2026-04-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07513597. Inclusion in this directory is not an endorsement.